Glenmark Pharmaceuticals Schedules Q3FY26 Results Earnings Call for February 02, 2026
Glenmark Pharmaceuticals Limited has scheduled its Q3FY26 results earnings call for February 02, 2026, from 8:30-9:30 AM IST. The company has provided multiple international dial-in numbers for global investor participation and notified stock exchanges under Regulation 30 compliance. The earnings call recording will be available on the company website within 24 hours of completion.
*this image is generated using AI for illustrative purposes only.
Glenmark Pharmaceuticals Limited has announced its quarterly earnings call to discuss Q3FY26 financial results, scheduled for Monday, February 02, 2026. The pharmaceutical company has formally notified stock exchanges BSE and NSE about this investor communication event under regulatory compliance requirements.
Earnings Call Schedule and Access Details
The Q3FY26 results discussion will be conducted as a conference call with specific timing and access arrangements for investors and analysts.
| Parameter: | Details |
|---|---|
| Date: | Monday, February 02, 2026 |
| Time: | 8:30 AM – 9:30 AM (IST) |
| Duration: | 1 Hour |
| Format: | Conference Call |
Global Dial-in Access Numbers
The company has provided multiple international access numbers to accommodate global investor participation:
| Region: | Dial-in Number |
|---|---|
| India (Universal): | +91 22 6280 1298 |
| India (Alternative): | +91 22 7115 8199 |
| USA: | 1 866 746 2133 |
| UK: | 0 808 101 1573 |
| Singapore: | 800 101 2045 |
| Hong Kong: | 800 964 448 |
Registration and Contact Information
Participants can pre-register online through the company's designated registration portal. For any clarifications regarding the earnings call, investors can contact Utkarsh Gandhi at utkarsh.gandhi3@glenmarkpharma.com or phone +91 22 4018 9232.
Regulatory Compliance and Recording
The earnings call announcement was made under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Company Secretary and Compliance Officer Harish Kuber signed the official communication to both stock exchanges on January 22, 2026. The company has confirmed that the complete recording of the earnings call will be available on its official website within 24 hours of the call's completion, ensuring accessibility for stakeholders who cannot participate in the live session.
Historical Stock Returns for Glenmark Pharmaceuticals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.16% | -2.47% | -10.59% | -1.91% | +18.06% | +335.70% |
15
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
